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Lung function in healthy adults 353The study aim was to compare the lung function data of three representative population-
based German studies (Study of Health in Pomerania [SHIP-1], Cooperative Health Research
in the Region of Augsburg [KORA-S3] and European Community Respiratory Health Survey Erfurt
[ECRHS-I Erfurt]) with existing European spirometry reference values and to establish a new set
of comprehensive German prediction equations.
Methods: Spirometry was performed in 4133 participants of three population-based surveys
using almost identical standardised methods. Current and former smokers, subjects with
cardiopulmonary disorders or on medication with potential influence on lung function were
excluded. Sex specific prediction equations were established by quantile regression analyses.
Comparison was performed to existing European reference values.
Results: The healthy reference sample consisted of 1302 (516 male) individuals, aged 20e80
years. Sex specific comprehensive prediction equations adjusted for age and height are
provided. Significant differences were found in comparison to previous studies with
pronounced lower values of the current population if applying historic prediction equations.
Conclusion: The results contribute to the interpretation of lung function examination in
providing a comprehensive set of spirometry reference values obtained in a large number of
healthy volunteers. Whereas the differences in between the investigated studies are negli-
gible, striking divergence was detected in comparison to historic and recent European spirom-
etry prediction values.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
Spirometry is the most frequently performed lung function
test and considered as an important tool in medical
surveillance examinations of pulmonary diseases. Further-
more, spirometric parameters such as forced expiratory
volume over 1 s (FEV1) are independently correlated to the
risk of myocardial infarction, congestive heart failure,
stroke1,2 and mortality.3,4 The interpretation of lung func-
tion results usually relies on the comparison to reference
values derived from a healthy population. Variations in
these available data may be, above all, explained by the
kind of selection criteria applied. Furthermore, as for other
anthropometric measures such as height, cohort effects
have been described e that is, mean values within each age
group increase over time.5 A number of sets of prediction
equations are currently available for different populations.
Those most widely used in Europe are based on studies
published in the eighties and nineties of the last century,5e8
and may not represent the findings obtained in recent
populations. Recommendations on the establishment of
spirometric reference values propose data from cross-
sectional studies of non-smokers.9,10 Arguments for updat-
ing reference values on a regular basis and with respect to
elderly people are, amongst others, cohort effects and
newer technical equipment.11
The objectives of our study were (1) to calculate age and
sex specific German spirometric prediction equations on
the basis of apparently healthy individuals of three repre-
sentative population-based German studies (Study of
Health in Pomerania-1 [SHIP-1]), KORA-S3 Augsburg [Coop-
erative Health Research in the Region Augsburg] and
ECRHS-I Erfurt [(European Community Respiratory Health
Survey in Adults)], (2) to compare the lung function data of
the present sample to historic and recent European
prediction equations for lung function, and12 to decide on
the validity and feasibility of the current spirometric
reference values as comprehensive German normative
equations.Material and methods
Study population
Three population-based studies were performed in different
German regions (northeast, central, south). Of the adult
population living in these areas defined samples were
selected from the population registration offices, where all
Germans inhabitants are registered. A two-stage cluster
sampling method was adopted from the WHO MONICA
Project Augsburg, Germany.13 Representative samples of
equally distributed sex and age groups were drawn. Eventual
participation was voluntary.
SHIP-1
SHIP is a population-based survey in a region in the Northeast
of Germany. Study details are given elsewhere.14e16 A first
5-year follow-up was performed (SHIP-1) 2003e2006. The
sample (without migrated, deceased and non-responding
people) compromised 3300 subjects (1584 males) aged
25e85 years. Lung function examination was performed on
a sub-sample consisting of 1809 individuals (885males). 1783
were younger than 80 years and had complete data on lung
function. Of these, 513 subjects with self-reported bronchial
asthma, chronic obstructive bronchitis or other pulmonary
diseases or use of specific pulmonary and cardiacmedication
were excluded. Furthermore, 35 subjects with fractional
shortening <20% and 687 current or ex-smokers were
excluded. Altogether data of 541 individuals were available
for the present analyses.
KORA-S3 Augsburg
The population-based study KORA-S3 is based on the third
MONICA survey, whichwas performed in Augsburg, Germany,
1994e1995. The objective and protocol of the underlying
MONICA surveys have been published earlier.17 For the
KORA-S3 survey an enriched sample of the 3rd MONICA
survey was drawn according to the presence of specific
IgE-antibodies and reported allergy symptoms. Details on
354 B. Koch et al.the sampling procedure have been published elsewhere.18 In
the subproject “KORA-C”, which specifically focussed on
allergic diseases, lung function tests were performed from
1997 to 1998 in a total of 1093 subjects, where 1085
participants had complete data. Of these, 185 subjects with
self-reported asthma, or cough or use of specific pulmonary
and cardiac medication were excluded. Furthermore, 17
subjects with heart failure and 557 current or ex-smokers
were excluded. Altogether data of 326 individuals were
available for the present analyses.
ECRHS-I Erfurt
The cross-sectional study ECRHS-I Erfurt was performed from
1991 to 1992 in Erfurt, Germany. The study design has been
described in detail before.19,20 In a two-step approach 6291
randomly chosen individuals were asked to reply to a short
questionnaire on respiratory symptoms (stage I). A random
sample of the 4332 stage I-responders, aged 20e65, were
invited to perform lung function measurement and to answer
a detailed questionnaire (stage II). Ultimately, 1231 lung
function tests were available and complete data were
present of 1161 subjects. Of these, 161 subjects with self-
reported asthma, or cough or use of specific pulmonary and
cardiacmedicationwereexcluded. Furthermore, 565 current
or ex-smokers were excluded. Altogether data of 435 indi-
viduals were used for the present analyses.
Computer-assisted standardised interviews and ques-
tionnaires were part of the three studies. Besides, data on
age and sex, information on sociodemographic parameters
and medical histories were assessed and anthropometric
measurements performed.
Lung function examinations were based on the ATS and
ERS quality standards.6,7,10 The standard operating proce-
dures of the three studies are very similar regarding tech-
nical equipment, examination andmeasurement procedures
as well as quality control. The operations were conducted by
experienced, trained and certified staff. All examiners were
trained in an experienced clinical department before
entering the study. Initial certification was awarded to
potential observers, who were held to strict quality criteria.
The follow-up quality was assured. External observers were
regularly invited to participate in certification procedures.
The data collection phase was monitored by a Data Safety
and Monitoring Committee.
Participants of all studies were investigated in health
examination centres established for the purpose of the
study and gave written informed consent. The studies
conformed to the principles of the Declaration of Helsinki
as reflected by approvals of the Ethics Committees.
Pre-diagnostics and exclusion criteria
The definition of pulmonary disorders was based on self-
reported physician’s diagnosis and the use of specific medi-
cation (based on the anatomic, therapeutic, and chemical
[ATC] code).21
Height and weight were measured without shoes
according to the ATS recommendations on preparing the
participants.9 The medication was recorded by a computer-
aided method using the ATC code. The smoking status
(current, former, or never-smoker) was assessed by self-report. Chronic bronchitis was defined as productive cough
in the past 12 months for at least 3 months. Bronchial
asthma and pulmonary disease were based on self-report.
Subjects fulfilling the following self-reported criteria
were excluded from the present study: current smoking, any
pulmonary diseases, bronchial asthma, chronic obstructive
bronchitis, or the use of specific pulmonary and cardiac
medication.
Spirometry and lung function variables
In all three studies lung function examinations were con-
ducted using comparable equipment produced by Jaeger,
Hoechberg, Germany, that meets the American Thoracic
Society (ATS) criteria22 and the recommendations of the
ECCS.6 The volume signal of the equipment was calibrated
with a 3.0 L syringe connected to the pneumotachograph in
accordance with the manufacturers’ recommendations and
at least once on each days’ testing. Barometric pressure,
temperature and relative humidity were registered every
morning. Calibration was examined under ambient temper-
ature and pressure conditions (ATP) and the integrated
volumes were BTPS (Body Temperature Pressure Saturated)
corrected.10,22
The participants performed at least three forced expira-
tory lung function manoeuvres in order to obtain a minimum
of two acceptable and reproducible values.6 Immediate on-
screen error codes indicated the major acceptability
(including start, duration and end of test) and reproducibility
criteria. The procedure was continuously monitored by
a physician. Before the tests the required manoeuvres were
demonstrated by the operator and the individuals were
encouraged and supervised throughout the performance of
tests. Lung function variables were measured continuously
throughout the baseline breathing and the forced manoeu-
vres. Spirometry flow volume loops were conducted in
accordance with ATS recommendations10 in a sitting position
and with wearing noseclips.
The best results for forced vital capacity (FVC) and FEV1
were taken. The ratio of FEV1 to FVC (expressed as
a percentage) was calculated from the largest FEV1 and FVC.
Statistical analyses
Continuous data are expressed as median (25th and 75th
percentiles). For unadjusted bivariate analyses, Krus-
kaleWallis tests were used to compare SHIP-1, KORA-S3,
and ECRHS-I Erfurt separately in men and women. To
account for the different age distributions, comparisons
were also performed by Analysis of Covariance with age and
weight as covariates. Quantile regression23 was used for the
evaluation of prediction equations in men and women
separately. In comparison to linear regression, quantile
regression represents a more adequate method to calcu-
lated reference ranges because it makes no distributional
assumption and allows an independent estimation of
conditional quantile functions resulting in reference limits
which are independent of global parameters like the stan-
dard deviation.21 Furthermore, the quantile regression
shows a high robustness to outlier observations. Models
adjusted for age and height were developed in order to
Lung function in healthy adults 355estimate the 5th, 50th, and 95th percentile. Likelihood
ratio tests were used to compare the fit of models with
different polynomials for the parameters age and height.
Since quantile regression makes no distributional assump-
tion, an initial transformation of the original data was not
necessary. The determined prediction equations for FEV1
and FVC were compared to formerly stated equa-
tions.5,6,24e27 For these, differences between observed and
predicted values are given as mean difference, root mean
square error of prediction, and residual prediction devia-
tion. Furthermore, Bland Altman plots were calculated to
present differences between predictions form the present
study and other equations. Moreover, graphical compari-
sons were performed by dummy calculations across all ages
and with fixed heights (women 165 cm, men 180 cm) of the
lower reference limit. Bland Altman plots and dummy
calculations were only presented for the European studies
of Falaschetti et al.,24 the European Community for Coal
and Steel [ECCS],6 Langhammer et al.,27 and Kuster et al.26
Statistical analyses were performed with PROC QUANTREG
in SAS 9.1.3 (SAS Institute Inc., Cary, NC, USA). A value of
p < 0.05 was considered statistically significant.Table 1 Descriptive statistics of the study population.
SHIP-1 KORA-S3
Men, N 186 172
Age (years) 47 (37; 60) 48 (39; 55)
Age (years, %)
20e29 5.4 2.9
30e39 29.1 25.0
40e49 21.5 26.7
50e59 17.7 43.6
60e69 23.1 1.2
70 3.2 0.6
Weight (kg) 82 (75; 93) 82 (76; 90)
Height (cm) 178 (171; 181) 178 (174; 182)
BMI (kg/cm2) 26.7 (24.3; 29.0) 26.2 (24.6; 27.
FEV1 (l) 4.0 (3.6; 4.7) 4.1 (3.5; 4.6)
FVC (l) 4.7 (4.2; 5.3) 5.0 (4.4; 5.6)
FEV1/FVC 0.86 (0.82; 0.89) 0.82 (0.79; 0.8
Women, N 355 154
Age (years) 54 (44; 64) 44 (39; 50)
Age (years, %)
20e29 3.4 1.3
30e39 15.8 30.5
40e49 15.2 39.6
50e59 25.4 27.3
60e69 30.4 1.3
70 9.8 e
Weight (kg) 70 (61; 80) 62 (57; 70)
Height (cm) 163 (159; 167) 164 (160; 167)
BMI (kg/cm2) 26.3 (23.3; 30.3) 23.5 (21.5; 26.
FEV1 (l) 2.7 (2.4; 3.2) 3.1 (2.8; 3.4)
FVC (l) 3.2 (2.8; 3.7) 3.6 (3.2; 4.0)
FEV1/FVC 0.87 (0.83; 0.90) 0.85 (0.82; 0.8
Continuous data are given as median (25th; 75th percentile). *Kruskal
and weight as a covariate. BMI (kg/m2): body mass index; FEV1 (l): for
FVC: ratio of FEV1 to FVC.Results
The study population consisted of 1302 individuals (516
male, 786 female) distributing on the studies as follows:
SHIP-1 541 subjects (186 male), KORA-S3 326 individuals
(172 male) and ECRHS-I Erfurt 435 participants (158
male).
Anthropometric and lung function data of the subjects
included in the present study are given in Table 1. Signifi-
cant differences between the study centres were evident in
both sexes for weight, body mass index (BMI), FEV1, FVC,
and FEV1/FVC. After adjustment for age and weight
differences were still apparent for FEV1/FVC in both men
and women as well as for FEV1 in women only.
Sex specific spirometry prediction equations from the
healthy individuals for the 5th, 50th, and 95th percentile of
FEV1, FVC, and FEV1/FVC are presented in Table 2 and
Fig. 1. The threshold limit value of a lung function param-
eter stipulates that 90% of healthy subjects are in the range
of normality. Fig. 1 illustrates that both age and height
account for variation in the reference limits except for
FEV1/FVC where the effect of height is less pronounced.ECRHS-I p* p**
158
38 (27; 50) <0.01 e
<0.01 e
30.4
22.1
20.9
23.4
3.2
e
78 (71; 86) <0.01 e
178 (172; 182) 0.59 0.43
8) 24.9 (23.1; 27.3) <0.01 0.49
4.3 (3.8; 4.7) <0.01 0.73
5.3 (4.6; 5.7) <0.01 0.08
6) 0.84 (0.80; 0.87) <0.01 <0.01
277
45 (36; 55) <0.01 e
<0.01 e
14.8
19.9
24.9
27.8
12.6
e
65 (58; 75) <0.01 e
163 (159; 168) 0.99 0.11
0) 24.2 (22.1; 28.1) <0.01 0.14
3.0 (2.6; 3.3) <0.01 <0.01
3.6 (3.2; 4.0) <0.01 0.14
8) 0.83 (0.79; 0.86) <0.01 <0.01
eWallis test. **Comparisons from Analysis of Covariance with age
ced expiratory volume in 1 s; FVC (l): forced vital capacity; FEV1/
Table 2 Prediction equations for spirometric parameters in men and women.
Variable Men Women
95th percentile
FEV1 3.82483 e 0.02728  Aþ0.05706  H 2.41455 e 0.02304  Aþ0.04299  H
FVC 5.40368 e 0.02821  Aþ0.07144  H 4.62277 þ 0.00772  A  0.00032  A2 þ 0.05625  H
FEV1/FVC 0.99017  0.00080  A  0.00014  H 1.42200  0.00660  A þ 0.00005  A2  0.00171  H
50th percentile
FEV1 3.20190 e 0.02358  A þ 0.04746  H 1.54700 e 0.02401  A þ 0.03463  H
FVC 5.23148 e 0.02426  A þ 0.06383  H 3.38781 þ 0.00577  A  0.00032  A2 þ 0.04504  H
FEV1/FVC 1.01247  0.00056  A  0.00085  H 1.14288  0.00507  A þ 0.00004  A2  0.00099  H
5th percentile
FEV1 3.48761 e 0.02085  A þ 0.04409  H 0.02351 e 0.02644  A þ 0.02190  H
FVC 4.48344 e 0.02125  A þ 0.05390  H 2.02079 þ 0.01622  A  0.00049  A2 þ 0.03214  H
FEV1/FVC 1.02786  0.00078  A  0.00148  H 1.44424  0.00523  A þ 0.00004  A2  0.00330  H
A Z age [years], H Z height [cm].
356 B. Koch et al.The calculated reference equations for FEV1 and FVC
were compared to established equations provided by
different studies: (a) Bra¨ndli et al.,5 (b) Falaschetti et al.,24
(c) Langhammer et al.,27 (d) Kuster et al.,26 (e) ECCS,6 and
(f) National Health and Nutrition Examination Survey III
[NHANES III].25 Differences between observed and pre-
dicted values of FEV1 and FVC are shown in Table 3. In both
women and men, equations from Bra¨ndli et al.5 and Lang-
hammer et al.27 showed the best fit to the present FEV1
data. Whereas equations of Falaschetti et al.,24 Kuster
et al.,26 and the ECCS6 underestimated FEV1 resulting inFigure 1 Upper (95th percentile) und lower reference (5th perce
vital capacity (FVC) and FEV1/FVC ratio depending on age in womea lower proportion of subjects below the lower limit of
normal range (LLN) with the most profound difference to
the ECCS equation. The Bland Altman plots (Figs. 2 and 3)
confirm these findings and dummy calculations showed
graphically that the lower values become even more
pronounced in older male subjects.
Regarding FVC, the closet agreement was with Fala-
schetti et al.24 and Kuster et al.26 in women and men
(Table 3). Whereas the ECCS6 again underpredicted the
FVC, equations from Langhammer et al.,27 Bra¨ndli et al.,5
and NHANES25 overestimated FVC (Figs. 2 and 3). Also forntile) limits for forced expiratory volume in 1 s (FEV1), forced
n and men for selected heights.
Table 3 Comparison of observed values of forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) with predicted values by different studies.
Men (n Z 516) Women (n Z 786)
Mean difference
(%)  SD
Root mean
square error
of prediction
Residual
prediction
deviation
Observed
values below
the LLN N (%)
Mean difference
(%)  SD
Root mean
square error
of prediction
Residual
prediction
deviation
Observed
values below
the LLN N (%)
FEV1
Present study 0.060  12.331 0.511 1.405 24 (4.7) 1.948  13.879 0.370 1.540 41 (5.2)
Bra¨ndli et al. 0.970  12.369 0.515 1.393 23 (4.5) 1.017  13.814 0.370 1.538 33 (4.2)
Falaschetti et al. 3.431  12.746 0.543 1.323 13 (2.5) 3.733  13.899 0.388 1.469 32 (4.1)
Langhammer et al. 0.263  12.413 0.513 1.400 29 (5.6) 1.114  13.847 0.367 1.550 53 (6.7)
Kuster et al. 4.871  12.457 0.560 1.282 9 (1.7) 4.444  13.848 0.398 1.431 31 (3.9)
NHANES 3.260  12.584 0.537 1.336 15 (2.9) 1.710  13.924 0.376 1.513 32 (4.1)
ECCS 8.320  12.548 0.624 1.150 3 (0.6) 9.541  14.188 0.463 1.231 14 (1.8)
FVC
Present study 0.072  11.743 0.590 1.419 25 (4.8) 0.853  12.813 0.418 1.562 41 (5.2)
Bra¨ndli et al. 5.614  11.911 0.645 1.299 49 (9.5) 6.496  13.156 0.466 1.403 52 (6.6)
Falaschetti et al. 0.985  11.878 0.596 1.406 12 (2.3) 0.157  12.781 0.418 1.564 30 (3.8)
Langhammer et al. 2.202  11.926 0.609 1.375 34 (6.6) 3.515  12.800 0.427 1.530 59 (7.5)
Kuster et al. 2.133  11.902 0.614 1.364 10 (1.9) 1.069  12.985 0.430 1.521 25 (3.2)
NHANES 2.398  11.776 0.597 1.402 34 (6.6) 3.863  13.173 0.439 1.488 59 (7.5)
ECCS 6.071  11.765 0.675 1.240 8 (1.6) 10.639  12.977 0.560 1.167 10 (1.3)
SD Z standard deviation; LLN Z Lower limit of normal range.
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Figure 2 Differences between mean forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) predicted by the
present study compared to Falaschetti et al.24 (A, E), ECCS6 (B, F), Langhammer et al.27 (C, G), and Kuster et al.26 (D, H) in women.
358 B. Koch et al.FVC, dummy calculations revealed that the lower values by
ECCS6 in men and the higher values by Langhammer et al.27
in women were more striking in older age (Fig. 4).Discussion
The current study provides reference equations for predict-
ing lung function values of three population-representative
studies of volunteers using the platform of population-based
German studies e SHIP-1, KORA-S3 and ECRHS-I Erfurt. By
excluding subjects with known cardiopulmonary disorders,
certain cardiovascular risk factors, such as current and
former smoking, or the use of specific pulmonarymedication,
and applying the ATS test performance criteria during data
collection10 an apparently disease-free population was
createdand reproducible valueswere obtained in thepresent
analyses.
The present study, as others before,5,24e27 confirms that
the ECCS6 prediction equations, which are still the most
commonly used in Europe, significantly underestimate FEV1and FVC. As FEV1 in percent of predicted still most
commonly reflects the severity of airflow limitation, the
choice of reference values may therefore be of clinical
importance.
Whereas the results of the three studies showed
remarkable equation conformity if analysed separately,
striking discrepancies were observed not only in comparison
to historic but also to recent European prediction equations.
These can, to some extent, be explained by methodological,
technical and personnel (e.g. equipment, observers) factors
influencing spirometric measurements.9,28 The contribution
of a cohort effect cannot be completely ruled out.29 In case
of changes in individual, behavioural and environmental
factors over decades, cross-sectional lung function will
increase by up to 5 ml/year for FEV1 and FVC.
30 Further, the
emphasis on quality control in the current study might be an
explanation for the higher values in comparison to previous
studies. However, regarding standardised preparing and
measuring procedures according to the ERS and ATS guide-
lines good conformity should be evident at least among
recent European studies, where ethnical differences do not
Figure 3 Differences between mean forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC) predicted by the
present study compared to Falaschetti et al.24 (A, E), ECCS6 (B, F), Langhammer et al.27 (C, G), and Kuster et al.26 (D, H) in men.
Lung function in healthy adults 359seem to play a major role.8 In both women and men, equa-
tions from Bra¨ndli et al.5 and Langhammer et al.27 showed
the best fit to the present FEV1 data, whereas equations of
Falaschetti et al.24 and Kuster et al.26 underestimated FEV1.
The definition of cardiorespiratory health is quite diffi-
cult to agree upon. The ATS spirometry interpretation
workshop only states that subjects should be “never-
smokers, free of respiratory symptoms and disease”.9 In
accordance to these guidelines, all individuals with known
pulmonary dysfunction or disease, specific medication as
well as former and current smokers were excluded. The
exclusion of former and current smokers is justified by
epidemiological and clinical experience that has shown
a decline of lung function in smokers.12,31
A recent study on prediction models of lung function,
based on the same three German populations has shown,
that besides age and height, body weight, and the presence
of obesity were associated with changes in lung function.35
However, as these analyses indicated, simple models with
gender, age and height explain a substantial part of lung
function variance whereas further determinants add less
than 5% to the total explained r-squared, at least for FEV1
and FVC, only age and height were included into the pre-
sented prediction equations.Differences between the studies on spirometric norma-
tive values lie, above all, in the selection of participants.
The ECCS reference equations were obtained by summa-
rising published regression equations from a survey pub-
lished between the 1950s an 1980s, including different
populations and using different spirometers and tech-
niques.6 The population-based design of recent European
studies on lung function reference values5,24e27 makes the
data reasonably comparable to the current investigations.
The differences between the prediction equations from the
ECCS6 and later studies, including the present, may be the
result of an increase in lung function,30 different exclusion
criteria for the reference sample and the use of quality
controls, such as feedback on acceptability and reproduc-
ibility5 in recent investigations. It might even be possible
that an increased awareness of respiratory symptoms
among the population results in the selection of a healthier
population in recent reference samples. A selection bias
towards a healthier population in the elderly group in
recent European studies might additionally be responsible
for the differences found in comparison to historic data.
The associations between FEV1, FVC and age found in
this population are similar to results from previous cross-
sectional studies.24,25,32,33 However, as for most of the
Figure 4 Lower limits of normal range for forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC) and FEV1/FVC ratio
predicted by different studies in men (fixed height at 180 cm) and women (grey shaded: fixed height at 165 cm):C present study,
A Falaschetti et al.,24 , ECCS,6 6 Langhammer et al.,27 and B Kuster et al.26
360 B. Koch et al.compared European studies, the levels were higher across
all ages in the present analyses.
The major strengths of the preset study lie in the use of
data from large population-based samples of adults, in
excluding subjects with relevant influencing diseases and in
the application of almost identical methods for lung func-
tion testing across the different study regions.
However, the present study has some limitations as data
show a selection bias towards including younger and
healthier individuals due to voluntariness. The ranges of
response patterns indicate that individual responses vary
widely. This has to be taken into account when analysing
spirometry data. A further limitation may lie in slightly
different software versions used among the three studies.
However, the pneumotachographs and the calibration
procedures were identical.
Moreover, no chest radiographical examinations were
performed, which may result in the inclusion of patients
with unknown asymptomatic lung disease. Further, cohort
effects because of examination time diversities as well as
differences in participant selection are not negligible. It
remains unclear how environmental characteristics didinfluence our lung function results. There might be an
increased exposure to environmental and occupational
pollution, including ozone, nitrogen dioxide, sulfur dioxide,
dust, chemicals and gases, all of which are known to have
adverse effects on lung function,34 especially in those
participants from urban areas. However, recent analyses on
prediction models of lung function have indicated, that
gender, age and height were the major determinants of
lung function in the three presented German populations
and their effect was similar across the study areas.35
Additionally, a bias due to a small number of included
individuals above the age of 70 years and available only
from SHIP as well as only few participants of KORA an ECRHS
above the age of 60 years limits the applicability of the
prediction equations in older subjects. Further studies in
these age groups are urgently needed.Conclusion
In summary, this study details lung function responses in
healthy subjects. The present results demonstrate that
Lung function in healthy adults 361especially sex, age, and behavioural characteristics should
be considered in the assessment of normalcy. We have
presented the results of this study in several ways, partly to
allow the investigator to compare studies in other labora-
tories with those of the present study and to permit
a flexible approach to the interpretation of lung function.
Our data indicate that the use of the ECCS prediction
values may provoke lower spirometric values in recent pop-
ulations. Therefore, healthcare providers are encouraged
to reconsider their choice of prediction equations of spi-
rometry. Reflecting on the present analyses, the establish-
ment of nationwide prediction equations seems advisable.
However, the results underscore that spirometric prediction
equations should be derived from a population most similar
to that for which the equations are to be used and based
on measurements obtained by the same instruments and
testing procedures as well as for the specific age range.
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